Reports of a respiratory disease called human metapneumovirus (hMPV) spreading in China have stoked fears and misinformation on social media. Some posts claimed that this is a new virus and that ...

Human metapneumovirus (HMPV) is another in the catalog of respiratory viruses causing a stir. The virus peaked in spring, affecting a number of children and the elderly, per CNN. Most of the time ...

-- 美国IND批准和重复接种临床试验的启动将全面支持三叶草生物及其 RSV PreF 候选疫苗（SCB-1019）把握全球差异化的机遇（该候选疫苗基于已经验证的 Trimer-Tag 蛋白质三聚体化疫苗研发平台）-- -- 针对SCB-1019 ...

Human metapneumovirus (HMPV), although discovered in 2001, is making headlines after an unspecified increase in cases was reported in China. Although it has not been officially pronounced by local ...

Human metapneumovirus (hMPV), a negative, single-stranded RNA virus, accounts for approximately 5-15% of infant respiratory tract infections and poses a severe risk of disease and hospitalization ...

(Background image: People wearing protective face masks as a preventive measure against the spread of HMPV in India/Right image: Prof Sarath Ranganathan, a Melbourne-based expert in respiratory ...

The HMPV is a respiratory virus that can cause mild to severe illness. The vulnerable group includes young children, older adults, and individuals with weakened immune systems A one-year-old girl ...

【财华社讯】三叶草生物-B(02197.HK)公布，公司RSV候选疫苗SCB-1019(未使用佐剂的二价RSVPreF-三聚体亚单位候选疫苗，基于三叶草生物Trimer-Tag蛋白质三聚体化疫苗研发平台)已获美国食品药品监督管理局(FDA)临床申报( ...

正在美国进行的重复接种Ⅰ期临床试验招募了多达160名老年受试者 (60-85岁)，他们在至少2个流行季前接种过首剂来自GSK的RSV疫苗 (AREXVY)，受试者将随机分组接受SCB-1019的异源重复接种、AREXVY的同源重复接种或生理盐水安慰剂。该研究将评估SCB-1019在重复接种方案中的安全性、反应原性和免疫原性。此外，针对SCB-1019在呼吸道联合疫苗 ...